Perspective: Limiting Antimicrobial Resistance with Artificial Intelligence/Machine Learning
BME Frontiers · 2023-01 · 4
DOI: 10.34133/bmef.0033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BME Frontiers, online erschienen am 15.12.2023. Verfasst von Daniel Amsterdam. Beteiligte Einrichtung: Jacobs School of Medicine & Biomedical Sciences, State University of New York, Buffalo, NY, USA. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The author traces his experience with the application of computers in clinical microbiology over the past 60 years, specifically in directing clinicians to treat bacterial infections diagnosed by the laboratory and the antibacterial agent(s) that could be used to treat those infections. Appropriate use of antibiotics will result in reduced antimicrobial resistance, which is increasing worldwide. An early form of AI, Mycin (1976), a system based on rules provided by experts designed to propose antibiotic regimens for central nervous system infections, was never applied due to the limitations in the number of rules that could be incorporated into the clinical workflow. Machine learning (ML) was developed to overcome the limitations of expert systems. Several variables that influence the outcome bacteria/drug interaction, such as the source of the infection, absence of antimicrobial resistance markers, patients’ health profile, and the historical susceptibility within the hospital and the local area are incorporated in the proposed comprehensive AI/ML program. The role of AI in the discovery of new antimicrobial agents is also addressed.
Autor:innen und Institutionen
- Jacobs School of Medicine & Biomedical Sciences, State University of New York, Buffalo, NY, USA.
- Departments of Microbiology and Immunology, Medicine, and Pathology at the Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.
- Department of Laboratory Medicine, ECMC, Buffalo, NY, USA. Address correspondence to: amsterda@buffalo.edu.
ORCID-Profile: Daniel Amsterdam
Zitieren
APA
Amsterdam, D. (2023). Perspective: Limiting Antimicrobial Resistance with Artificial Intelligence/Machine Learning. BME Frontiers, 4. https://doi.org/10.34133/bmef.0033
Vancouver
Amsterdam D. Perspective: Limiting Antimicrobial Resistance with Artificial Intelligence/Machine Learning. BME Frontiers. 2023;4. doi:10.34133/bmef.0033
BibTeX
@article{Amsterdam2023,
author = {Amsterdam, Daniel},
title = {Perspective: Limiting Antimicrobial Resistance with Artificial Intelligence/Machine Learning},
journal = {BME Frontiers},
year = {2023},
volume = {4},
doi = {10.34133/bmef.0033}
}
EUVIMED